ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.
Alto Crescimento
A receita da empresa tem crescido de forma consistente nos últimos 3 anos, com média de 5407.52% ano a ano.
Em Crescimento
A empresa está em fase de crescimento, com a receita anual mais recente totalizando US$ 23.85M.
Alto Crescimento de Lucro
O lucro líquido da empresa lidera o setor, com o lucro anual mais recente totalizando US$ 23.85M.
Sobreavaliada
O PE mais recente da empresa é -2.75, em uma faixa percentil alta de 3 anos.
Compra Institucional
As participações institucionais mais recentes são de 73.95M ações, um aumento de 13.33% em relação ao trimestre anterior.
Mantido por ETHSX
O Super Investidor ETHSX possui 18.33K ações desta empresa.